Oxycodone, Screen
CPT Code(s):
80307
Turnaround Time:
8 hours
Specimen Requirements
Preferred Specimen:
Urine
Minimum Volume:
1.0 mL
Transport Container:
Yellow Top Tube or Sterile Cup
Transport Temperature:
Room Temperature
Collection Instructions:
Collect urine in plastic container and transfer to plain yellow top tube (without preservative).
Rejection Criteria:
Specimen received outside stability requirements; Excessive blood, particulates, viscosity present
Stability Criteria
Room Temperature:
24 hours
Refrigerated:
7 days
Frozen:
30 days
Clinical Significance
Oxycodone Screen, using immunoassay, has specific clinical significance and diagnostic use in detecting the presence of oxycodone, a potent opioid medication, in a patient's system. Oxycodone is commonly prescribed for the management of moderate to severe pain.
The specific clinical significance and diagnostic use of Oxycodone Screen include:
1. Drug Abuse Screening: The test is primarily used to screen for the presence of oxycodone in patients suspected of substance abuse or misuse. It is commonly employed in addiction treatment programs, pain management clinics, and workplace drug testing.
2. Rapid Detection: The immunoassay-based Oxycodone Screen provides quick results, allowing for timely intervention and appropriate patient management. It can help identify individuals who have recently used oxycodone and may require further evaluation or intervention.
3. Point-of-Care Testing: Oxycodone Screen can be performed at the point of care, such as in emergency departments, clinics, or rehabilitation centers, enabling immediate detection of oxycodone use. This facilitates timely decision-making and patient care.
4. Screening Tool: Oxycodone Screen serves as an initial screening tool to identify patients who may require confirmatorying using more sensitive and specific methods, such as liquid chromatography-tandem mass spectrometry (LC/MS-MS). Positive results from the screen test may prompt further testing to confirm oxycodone presence and quantify its concentration.
5. Monitoring Compliance: The test can be used to assess patient compliance with prescribed oxycodone therapy. It helps healthcare providers verify that patients are taking the medication as directed and not diverting it for illicit purposes.
6. Forensic Investigations: Oxycodone Screen has forensic applications, aiding in the detection and documentation of oxycodone use in legal and forensic contexts, such as impaired driving cases or medicolegal investigations.
It is important to note that Oxycodone Screen using immunoassay provides a preliminary result, which may have limitations in terms of sensitivity and specificity compared to confirmatory methods. Positive screen results should be confirmed using more accurate and specific techniques like LC/MS-MS.
In summary, Oxycodone Screen using immunoassay is clinically significant in detecting the presence of oxycodone in a patient's system. It serves as a rapid and convenient screening tool for drug abuse detection, compliance monitoring, and forensic investigations. Confirmatory testing using more specific methods may be necessary to confirm positive results from the screen test. Collaborative efforts between healthcare providers and laboratory professionals are essential to interpret the test results accurately and provide appropriate patient care.
CPT Code(s):
80307
Turnaround Time:
8 hours
Specimen Requirements
Preferred Specimen:
Urine
Minimum Volume:
1.0 mL
Transport Container:
Yellow Top Tube or Sterile Cup
Transport Temperature:
Room Temperature
Collection Instructions:
Collect urine in plastic container and transfer to plain yellow top tube (without preservative).
Rejection Criteria:
Specimen received outside stability requirements; Excessive blood, particulates, viscosity present
Stability Criteria
Room Temperature:
24 hours
Refrigerated:
7 days
Frozen:
30 days
Clinical Significance
Oxycodone Screen, using immunoassay, has specific clinical significance and diagnostic use in detecting the presence of oxycodone, a potent opioid medication, in a patient's system. Oxycodone is commonly prescribed for the management of moderate to severe pain.
The specific clinical significance and diagnostic use of Oxycodone Screen include:
1. Drug Abuse Screening: The test is primarily used to screen for the presence of oxycodone in patients suspected of substance abuse or misuse. It is commonly employed in addiction treatment programs, pain management clinics, and workplace drug testing.
2. Rapid Detection: The immunoassay-based Oxycodone Screen provides quick results, allowing for timely intervention and appropriate patient management. It can help identify individuals who have recently used oxycodone and may require further evaluation or intervention.
3. Point-of-Care Testing: Oxycodone Screen can be performed at the point of care, such as in emergency departments, clinics, or rehabilitation centers, enabling immediate detection of oxycodone use. This facilitates timely decision-making and patient care.
4. Screening Tool: Oxycodone Screen serves as an initial screening tool to identify patients who may require confirmatorying using more sensitive and specific methods, such as liquid chromatography-tandem mass spectrometry (LC/MS-MS). Positive results from the screen test may prompt further testing to confirm oxycodone presence and quantify its concentration.
5. Monitoring Compliance: The test can be used to assess patient compliance with prescribed oxycodone therapy. It helps healthcare providers verify that patients are taking the medication as directed and not diverting it for illicit purposes.
6. Forensic Investigations: Oxycodone Screen has forensic applications, aiding in the detection and documentation of oxycodone use in legal and forensic contexts, such as impaired driving cases or medicolegal investigations.
It is important to note that Oxycodone Screen using immunoassay provides a preliminary result, which may have limitations in terms of sensitivity and specificity compared to confirmatory methods. Positive screen results should be confirmed using more accurate and specific techniques like LC/MS-MS.
In summary, Oxycodone Screen using immunoassay is clinically significant in detecting the presence of oxycodone in a patient's system. It serves as a rapid and convenient screening tool for drug abuse detection, compliance monitoring, and forensic investigations. Confirmatory testing using more specific methods may be necessary to confirm positive results from the screen test. Collaborative efforts between healthcare providers and laboratory professionals are essential to interpret the test results accurately and provide appropriate patient care.
CPT Code(s):
80307
Turnaround Time:
8 hours
Specimen Requirements
Preferred Specimen:
Urine
Minimum Volume:
1.0 mL
Transport Container:
Yellow Top Tube or Sterile Cup
Transport Temperature:
Room Temperature
Collection Instructions:
Collect urine in plastic container and transfer to plain yellow top tube (without preservative).
Rejection Criteria:
Specimen received outside stability requirements; Excessive blood, particulates, viscosity present
Stability Criteria
Room Temperature:
24 hours
Refrigerated:
7 days
Frozen:
30 days
Clinical Significance
Oxycodone Screen, using immunoassay, has specific clinical significance and diagnostic use in detecting the presence of oxycodone, a potent opioid medication, in a patient's system. Oxycodone is commonly prescribed for the management of moderate to severe pain.
The specific clinical significance and diagnostic use of Oxycodone Screen include:
1. Drug Abuse Screening: The test is primarily used to screen for the presence of oxycodone in patients suspected of substance abuse or misuse. It is commonly employed in addiction treatment programs, pain management clinics, and workplace drug testing.
2. Rapid Detection: The immunoassay-based Oxycodone Screen provides quick results, allowing for timely intervention and appropriate patient management. It can help identify individuals who have recently used oxycodone and may require further evaluation or intervention.
3. Point-of-Care Testing: Oxycodone Screen can be performed at the point of care, such as in emergency departments, clinics, or rehabilitation centers, enabling immediate detection of oxycodone use. This facilitates timely decision-making and patient care.
4. Screening Tool: Oxycodone Screen serves as an initial screening tool to identify patients who may require confirmatorying using more sensitive and specific methods, such as liquid chromatography-tandem mass spectrometry (LC/MS-MS). Positive results from the screen test may prompt further testing to confirm oxycodone presence and quantify its concentration.
5. Monitoring Compliance: The test can be used to assess patient compliance with prescribed oxycodone therapy. It helps healthcare providers verify that patients are taking the medication as directed and not diverting it for illicit purposes.
6. Forensic Investigations: Oxycodone Screen has forensic applications, aiding in the detection and documentation of oxycodone use in legal and forensic contexts, such as impaired driving cases or medicolegal investigations.
It is important to note that Oxycodone Screen using immunoassay provides a preliminary result, which may have limitations in terms of sensitivity and specificity compared to confirmatory methods. Positive screen results should be confirmed using more accurate and specific techniques like LC/MS-MS.
In summary, Oxycodone Screen using immunoassay is clinically significant in detecting the presence of oxycodone in a patient's system. It serves as a rapid and convenient screening tool for drug abuse detection, compliance monitoring, and forensic investigations. Confirmatory testing using more specific methods may be necessary to confirm positive results from the screen test. Collaborative efforts between healthcare providers and laboratory professionals are essential to interpret the test results accurately and provide appropriate patient care.